Summary:
Tree nuts are nutrient-dense foods that provide unsaturated fats, fiber, plant protein, vitamins, minerals, and bioactive phytochemicals. Regular nut intake, including almonds, walnuts, pistachios, pecans, and hazelnuts, has been associated with improved cardiovascular health and reduced risk of chronic disease. Pecans share these health-promoting properties and also contain notable amounts of polyphenols, tocopherols, and plant sterols that may contribute additional biological effects. The U.S. Food and Drug Administration has issued a health claim indicating that daily consumption of approximately 1.5 ounces of most nuts, including pecans, may reduce the risk of heart disease. This narrative review examined the nutritional composition, bioavailability of bioactive compounds, and health effects of pecan consumption in humans. The authors included fifty-two articles published between 2000 and 2025 that met the inclusion criteria. Overall, the review reports that the phenolic profile of pecans varies according to cultivar, maturity, storage, and processing conditions. Evidence from human clinical trials indicates that substituting snacks or foods with pecans can improve overall diet quality and lipid profiles. Effects on vascular function, glycaemic control, and inflammatory markers are inconsistent. Body weight outcomes appear largely neutral, although some studies suggest favourable effects on satiety hormones and appetite regulation. Research examining cognitive and gut health outcomes remains limited and preliminary. In summary, current evidence from this narrative review supports a cardiometabolic benefit of pecans when consumed within healthy dietary patterns, but important evidence gaps remain. Future well-controlled studies in at-risk populations are needed to clarify the role of pecans in dietary guidance.
Abstract:
Pecans are a tree nut native to America with a rich content of unsaturated fatty acids, minerals, fiber, and a diverse array of bioactive components, including polyphenols, tocopherols, and phytosterols. This review summarizes variations in the phenolic composition of pecans from various parts of the world based on cultivar, maturity stage, postharvest storage, and processing. Additionally, the review delves into the bio-accessibility and bioavailability of bioactive components from pecans and their potential influence on diet quality, body weight, satiety, cardiometabolic, brain and gut health. Data from human clinical trials suggest that replacing foods/snacks with pecans improves overall diet quality and lipid profiles. However, inconsistent effects are observed on vascular function, glycemia, and inflammation. Body weight changes after pecan intake are reported as neutral, with promising results on satiety peptides and appetite regulation. Cognition and gut health are emerging areas of research with very limited data from both human and preclinical models, warranting further investigation. Overall, the current literature supports the cardiometabolic benefits of pecans within healthy dietary patterns. Future research should focus on well-controlled studies targeting at-risk populations to understand mechanistic endpoints such as metabolomics, microbiome, and vascular function assessments to substantiate the role of pecans in dietary guidance.
Article Publication Date: 25/11/2025
DOI: 10.3390/nu17233686
